Hemodialysis and Peritoneal Dialysis Market - The lucrative way to manage renal health
The innovations in the medical field has developed several business opportunities. One such lucrative profit making medical domain is hemodialysis and peritoneal dialysis. Few of the data written below is the testimony that the market is going to flourish.
Startling facts-
- As per a report by the WHO in 2019, kidney diseases accounted for 254,028 total deaths, 131,008 deaths in men, and 123,020 deaths in women.
- Chronic kidney disease (CKD) affects more than 10% of the general population worldwide, which comes close to 800 million individuals.
- Older individuals, women, racial minorities, and people with health conditions such as diabetes mellitus and hypertension are more susceptible to kidney problems.
- Kidney disease is most common in people aged between 65 to 74 years. 25% of the people younger than 60 years also experience kidney problems
- Non-communicable diseases (such as heart disease, diabetes, or kidney disease) have become the most common causes of premature death worldwide.
- An estimated 80% of this health burden occurs in low or middle-income countries.
- Request Report Sample@ https://www.researchnester.com/sample-request-4271
What is kidney malfunction?
The kidneys filter waste and excess fluid from the blood. When kidneys fail to perform their function, waste builds up. Symptoms may not show any specification of the disease or may appear slowly or may not appear at all but are diagnosed by a lab test. In advanced stages, dangerous levels of fluid, electrolytes, and wastes build up in the body leading to chronic kidney disease. At this stage, filtering of the blood with a machine (dialysis) at fixed intervals is required to avoid or postpone a kidney transplant.
Dialysis- a medical boon for kidney patients
Dialysis is a procedure through which waste products and excess fluids are removed from the blood to restrict their accumulation. In the case of chronic kidney disease, waste, and fluid can rise to dangerous levels causing unpleasant symptoms and even death, hence filtering or dialysis needs to be done by diverting the blood to a machine that cleans it.
Types of Dialysis
There are 2 main types of dialysis namely - hemodialysis and peritoneal dialysis.
Hemodialysis is the most common type of dialysis, in which a tube is attached to a needle in the arm through which the blood passes into an external machine that filters it. It is passed back into the arm through another tube.
- At dialysis centers, this is usually carried out 3 days a week, with each session lasting around 4 hours.
- At home, it can be done as per any of the following schedules
- 4 times a week for 4 hours
- 5 times a week for 3 hours
- 6 days a week for 8 hours overnight
In Peritoneal Dialysis, the inside lining of the patient’s belly acts as a natural filter. A soft plastic tube called a catheter is placed in the abdomen surgically and the abdominal area is filled with dialysate, which is a cleansing fluid. Wastes are taken out by washing in and out of the belly in cycles. After the filtering process is finished, the fluid flows out of the body through the catheter.
Hemodialysis and Peritoneal Dialysis –Market Research Synopsis
The current, estimated size and growth rate (CAGR) of the Hemodialysis and Peritoneal Dialysis Market
The global hemodialysis and peritoneal dialysis market size was valued at USD 89.2 billion as of 2022 and is expected to reach USD 160.5 billion growing at a compound annual growth rate (CAGR) of 7% from 2023 to 2035.
Trends positively favoring the market growth
- The growing incidence of chronic kidney disease (CKD) globally - An estimated 1 million people worldwide die from untreated kidney failure each year. According to the Centers for Disease Control and Prevention (CDC), more than 15% of U.S. adults are estimated to have CKD as of 2022.
- The increasing geriatric population worldwide- The share of the population aged 60 years and over is anticipated to increase from 1 billion in 2020 to 1.4 billion in 2030. By 2050, the world's population of people aged 60 years and older is expected to reach 2.1 billion.
- The high prevalence of diabetes and hypertension- In 2021, Approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.
- The introduction of innovative and advanced home-dialysis techniques- Technological advancements in the field of home-care dialysis have facilitated convenience with better efficacy in procedures.
- The spurt in collaborations and strategic developments by key players- Major players are collaborating and entering into strategic agreements for strengthening their positions in the market.
Trends negatively impacting the market growth
- The high capital investments involved in innovation and product development
- The cumbersome procedures for regulatory approval
- Stiff competition amongst market players and the difficulty in sustenance for small and medium-sized companies.
Research Nester recently published an article with a detailed and in-depth analysis of the Hemodialysis and Peritoneal Dialysis Market
The prominent players in the Hemodialysis and Peritoneal Dialysis Market Industry are-
Baxter; B. Braun Melsungen AG; Fresenius Medical Care AG; Medtronic; Asahi Kasei Medical Co., Ltd.; Nipro Corp.; DaVita Inc.; Nikkiso Co., Ltd.; and Cantel Medical.
Latest Developments in the field
- Fresenius Medical Care has closed the three-way merger including Fresenius Health Partners, forming the new company, with the brand name InterWell Health. It has satisfied customary closing conditions and received regulatory clearance in the U.S. InterWell Health’s clinical care models with a strong network of 1,700 nephrologists and Cricket Health’s tech-enabled care model and patient engagement platforms have created an innovative, stand-alone entity poised to transform kidney care.
- DaVita Inc has expanded its home kidney care program and added the HomeChoice Claria Automated Peritoneal Dialysis (APD) system enabled by Sharesource remote patient monitoring from Baxter International Inc., a global innovator in renal care.
Full Report Sample Here: - https://www.researchnester.com/reports/hemodialysis-and-peritoneal-dialysis-market/4271
Regional Distribution of the Hemodialysis and Peritoneal Dialysis Market
North America is estimated to dominate the market having the largest revenue share of over 35.0% as shown in 2021. Kidney disease is the ninth leading cause of death in the region. According to the Centers for Disease Control and Prevention (CDC), a staggering 37 million Americans are estimated to have kidney disease in the U.S. with almost 810,000 Americans living with kidney failure as of 2021 and 2 in every 1,000 people needing dialysis or a kidney transplant to survive. In 2018, 554,038 patients received dialysis to substitute kidney function and 229,887 got a kidney transplant. About 130,000 people started KFRT (kidney failure with replacement therapy) treatment in the same year, of which around 128,000 started dialysis as the initial mode of therapy. Apart from that, the presence of key players and government support is also boosting the market in this region.
The Asia Pacific region is estimated to grow at the highest CAGR of 7.6% over the forecast period considering the growing geriatric population in China, India, and Japan, the increasing prevalence of kidney diseases, and the availability of advanced medical facilities.
- In 2017, researchers estimated the total number of patients receiving dialysis in China to be 581,273, with the prevalence of patients on hemodialysis being 384.41 per million population and the prevalence of patients on peritoneal dialysis being 34.98 per million population. The number of patients on dialysis in China has risen to approximately 744,817 in 2020 and is expected to reach 874,373 patients by 2025.
- In India, as per a study conducted in 2018, the number of patients on chronic dialysis in India was around 175,000, showing a prevalence of 129 per million population. Hemodialysis (HD) is the common mode of dialysis and the penetration of peritoneal dialysis (PD) is very low. The number of HD stations in India in 2018 was estimated to be 12,881 while there were only about 8500 patients on PD in India in 2019. The union government announced a National Dialysis Program in 2016 that facilitated the setting up of an eight-station dialysis facility in all 688 districts of the country to provide HD to poor patients.
- The European Dialysis Market size was valued at approximately USD 26 billion in 2021 and is anticipated to exhibit a CAGR of 3.6% for the coming decade. Hemodialysis was the preferred mode capturing around 91% of the market share in this region and is estimated to grow with higher efficacy and more availability. Germany is considered to lead the market in this region considering its reimbursement policies and presence of advanced medical resources.
Request Report Sample@ https://www.researchnester.com/sample-request-4271
Conclusion:
In a nutshell, it can be said that dialysis is an indispensable part of managing chronic kidney disease (CKD) to avoid further deterioration of health. Hence the market for hemodialysis and peritoneal dialysis is anticipated to advance in terms of revenue generation for market players and investors in the coming decade. A recent report from Research Nester gives a detailed account of the market’s potential regarding its profitable growth.
About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
